Upload
gbk
View
21
Download
5
Tags:
Embed Size (px)
DESCRIPTION
annual presentation
Citation preview
www.bharatbiotech.com
Corporate Profile 2014
www.bharatbiotech.com
Fast Facts
Issues
Products
R&D Pipeline
Projects
Recognition
Executive Summary
www.bharatbiotech.com
Fast Facts
www.bharatbiotech.com
Fast Facts Issues Products R&D Pipeline Projects Recognition
Established : 1996
Promoters : Dr. Krishna & Ms. Suchitra Ella
Business Line : Vaccines and Bio-therapeutics
First Project : Hepatitis B Vaccine - US $ 3.5 Mn
Investment : Over US $ 150 Mn till date
Facility : One of the largest facilities in Asia
Personnel : 700 resources including scientists
Accreditations : Korean FDA, ANVISA, other Countries
Innovation : 50 Global patents
Vision
Mission
To offer affordable, safe and effective healthcare
solutions to combat mankind's most dreaded illnesses, and to
thus eradicate or at least control their occurrence in the years to
come.
Developing next-generation remedies through Genetic
Engineering Technologies so as to create a healthier world.
Mission 7 Billion
www.bharatbiotech.com
Issues
www.bharatbiotech.com
Products R&D Pipeline Projects Recognition
Emerging Country Challenges
Lack of clarity on disease burden, public health focus & policies
NEG
LEC
TED
AP
PR
OA
CH
NEG
LEC
TED
DIS
EASE
S
1 TYPHOID
2 HEPATITIS
3 ROTA
4 SCHISTOSOMIASIS
5 E. COLI
6 CHOLERA
7 OTHER DIARRHEA
1 JE
2 DENGUE
3 CHIKUNGUNYA
4 MALARIA
5 TRYPANOSOMA
6 LEISHMANIA
7 FILARIA
POLITICAL COMMITTMENT
SCIENTIFIC COMMITTMENT
Fast Facts Issues
www.bharatbiotech.com
Products R&D Pipeline Projects Recognition
Thinking Future
Todays neglected diseases - Tomorrows global diseases
1 PLAGUE
2 HIV
3 INFLUENZA
4 MALARIA
1 DENGUE
2 CHIKUNGUNYA
3 TRYPANOSOMA
4 LEISHMANIA
5 FILARIA
6 JAPANESE ENCEPHALITIS
Fast Facts Issues
No DW manufactures develop new vaccines. Most DW manufactures are biogeneric players. DC manufactures follow MNCs. Our Mission is to change that mindset.
NEGLECTED DISEASES
GLOBAL DISEASES
www.bharatbiotech.com
Emerging Market Value Proposition
Bharat Biotech Strategy
Population
Birth Cohort
Health Care Budgets Increasing
Health Care Budgets Decreasing
Our growth path for future is here
Emerging
6 Billion
125 Million
Low Value
High Volume
Products R&D Pipeline Projects Recognition Fast Facts Issues
Developed
0.75 Billion
7.5 Million
High Value
Low Volume
www.bharatbiotech.com
Products
www.bharatbiotech.com
JE Launch
The Union Health & Family Welfare Minister, Shri Ghulam Nabi Azad launching
Japanese Encephalitis vaccine on 04th October, 2013 in New Delhi
Products R&D Pipeline Projects Recognition Issues Fast Facts
Purified, Inactivated Japanese Encephalitis Vaccine
1st indigenously developed
www.bharatbiotech.com
TCV Launch
Products R&D Pipeline Projects Recognition Issues Fast Facts
Vi Capsular Polysaccharide Tetanus Toxoid Conjugate Vaccine
Worlds 1st Clinically Proven Typhoid Conjugate Vaccine
Dr. Christian Loucq - International Vaccine Institute Director-General launching
Typhoid Conjugate Vaccine in Hyderabad on 26th August, 2013
www.bharatbiotech.com
Products R&D Pipeline Projects Recognition
Product Launches
Dr. A.P.J. Abdul Kalam Former President of India, launching
Dr. John Robbins Father of Polysaccharide Vaccine National Institute of Health, USA, launching
Dr. Julie Gerberding Former Director of the U.S. Centers for Disease Control, launching
Issues Fast Facts
www.bharatbiotech.com
Vaccines
Wide Product Portfolio
S. No. Vaccine Brand
1 DPT+ Hep B + Hib Comvac 5
2 DPT+ Hep B Comvac 4-Hb
3 DPT; TT, DT Comvac 3
4 Hep B Revac B+
5 Hep B Revac B mcf
6 Hib BioHib
7 Typhoid Typbar
8 Typhoid Typbar TCV
9 OPV Trivalent BIOPOLIO
10 OPV Monovalent Type-1 BIOPOLIO M1
11 OPV Monovalent Type-3 BIOPOLIO M3
12 OPV Bivalent BIOPOLIO B1/3
13 JE Jenvac
Products R&D Pipeline Projects Recognition Issues Fast Facts
S. No. Vaccine Brand
1 Typhoid Typbar
2 Typhoid Typbar TCV
3 Rabies INDIRAB
4 Influenza HN VAC
5 JE Jenvac
S. No. Vaccine Brand
1 Typhoid Typbar
2 Typhoid Typbar TCV
3 Influenza HN VAC
4 JE Jenvac
Children & Adult
Traveler
Children
www.bharatbiotech.com
Bio-therapeutics
Wide Product Portfolio
Products R&D Pipeline Projects Recognition Issues Fast Facts
S. No. Bio-therapeutic Brand
1 Probiotic Yeast BIOGIT
2 Recombinant Human Epidermal Growth Factor
REGEN-D
3 Recombinant Human Epidermal Growth Factor, Silver Sulfadiazine & Chlorexidine Gluconate Cream
SLVRGEN
4 Zinc with ORS ZELECT
www.bharatbiotech.com
Product Distribution
More than 2 Billion doses delivered
Products R&D Pipeline Projects Recognition Issues Fast Facts
www.bharatbiotech.com
More than 2 Billion doses delivered
Products R&D Pipeline Projects Recognition Issues Fast Facts
Korea
Nepal
Philippines
Brazil
(ANVISA)
Sri Lanka
Saudi Arabia
Colombia
(INVIMA)
Ghana Kenya Congo
Turkey Kazakhstan
Uganda
Syria
Malawi
Ukraine
Belarus
Ivory Coast
Accreditation
Pakistan Myanmar
www.bharatbiotech.com
R&D Pipeline
www.bharatbiotech.com
Products R&D Pipeline Projects Recognition
Pipeline Products
1st Time in the world Typhoid Conjugate Vaccine
S. No. Vaccines Product Development Preclinical
Testing Phase I Phase II Phase III Commercial
License
1 Chikungunya 2017
2 Malaria PvRII 2017
3 Staph Aureus MRSA 2018
4 Human Papilloma Virus 2018
5 Acellular Pertussis 2016
6 Tetanus (Meat Free) 2016
7 S. Paratyphi 2018
8 NTS Conjugates 2018
9 Sabin IPV 2018
Therapeutics Product Development Preclinical
Testing Phase I Phase II Phase III Commercial
License
1 THR-100 2015
2 Lysostaphin Topical 2015
3 Lysostaphin IV 2017
4 r Human Serum Albumin 2014
Issues Fast Facts
www.bharatbiotech.com
Projects
www.bharatbiotech.com
Recognition
www.bharatbiotech.com
Recognition of Achievements
Young Enterprising Company
Products R&D Pipeline Projects Recognition Issues Fast Facts
VOA awards 2013 most promising vaccines for paediatric
16th March, 2013
Pharma Bio World Award
Business Leader of the Year
Biotechnology 2011
Best R&D Company of the year 2010
by Pharmaceutical Leadership Summit
2010 Mumbai
National Technology
Award Govt of India 2006
Business Innovation Marico Foundation
& Business World 2006
www.bharatbiotech.com
Recognition of Achievements
Young Enterprising Company
Products R&D Pipeline Projects Recognition Issues Fast Facts
JRD TATA Best Entrepreneur award FICCI Award Excellence in Science
Best Performance in Technology
Marico Foundation Innovation Award
TDB National award DBT-award for Product & Process
www.bharatbiotech.com
Our mission is to address the health care needs of emerging markets, drive innovation, be a front runner in research and development of
new vaccines and bio-therapeutics
Mission 7 Billion
Dr. Krishna M. Ella Chairman & Managing Director
www.bharatbiotech.com
Thank You
Address
Products R&D Pipeline Projects Recognition Issues Fast Facts
Bharat Biotech International Limited Genome Valley, Shameerpet Mandal,
Ranga Reddy District - 500 078 Andhra Pradesh, India.
Tel.: +91 40 2348 0567 Fax: +91 40 2348 0560
[email protected] www.bharatbiotech.com